Li Xiang, Zhang Chuan-Tao, Ma Wei, Xie Xin, Huang Qun
Department of Ophthalmology, School of Pharmacy, College of Medical Technology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Department of Respiratory, School of Pharmacy, College of Medical Technology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Pharmacol. 2021 Jul 5;12:645824. doi: 10.3389/fphar.2021.645824. eCollection 2021.
Oridonin, as a natural terpenoids found in traditional Chinese herbal medicine (Hemsl.) H.Hara, is widely present in numerous Chinese medicine preparations. The purpose of this review focuses on providing the latest and comprehensive information on the pharmacology, pharmacokinetics and toxicity of oridonin, to excavate the therapeutic potential and explore promising ways to balance toxicity and efficacy of this natural compound. Information concerning oridonin was systematically collected from the authoritative internet database of PubMed, Elsevier, Web of Science, Wiley Online Library and Europe PMC applying a combination of keywords involving "pharmacology," "pharmacokinetics," and "toxicology". New evidence shows that oridonin possesses a wide range of pharmacological properties, including anticancer, anti-inflammatory, hepatorenal activities as well as cardioprotective protective activities and so on. Although significant advancement has been witnessed in this field, some basic and intricate issues still exist such as the specific mechanism of oridonin against related diseases not being clear. Moreover, several lines of evidence indicated that oridonin may exhibit adverse effects, even toxicity under specific circumstances, which sparked intense debate and concern about security of oridonin. Based on the current progress, future research directions should emphasize on 1) investigating the interrelationship between concentration and pharmacological effects as well as toxicity, 2) reducing pharmacological toxicity, and 3) modifying the structure of oridonin-one of the pivotal approaches to strengthen pharmacological activity and bioavailability. We hope that this review can provide some inspiration for the research of oridonin in the future.
冬凌草甲素作为一种存在于传统中药冬凌草中的天然萜类化合物,广泛存在于众多中药制剂中。本综述的目的是提供有关冬凌草甲素药理学、药代动力学和毒性的最新全面信息,以挖掘其治疗潜力,并探索平衡这种天然化合物毒性和疗效的有效方法。通过使用“药理学”、“药代动力学”和“毒理学”等关键词组合,从权威的互联网数据库PubMed、Elsevier、Web of Science、Wiley Online Library和Europe PMC中系统收集了有关冬凌草甲素的信息。新证据表明,冬凌草甲素具有广泛的药理特性,包括抗癌、抗炎、肝肾保护以及心脏保护等作用。尽管该领域已取得显著进展,但仍存在一些基本而复杂的问题,例如冬凌草甲素针对相关疾病的具体机制尚不清楚。此外,有几条证据表明,冬凌草甲素在特定情况下可能会产生不良反应,甚至毒性,这引发了对其安全性的激烈辩论和关注。基于目前的进展,未来的研究方向应着重于:1)研究浓度与药理作用以及毒性之间的相互关系;2)降低药理毒性;3)修饰冬凌草甲素的结构——这是增强药理活性和生物利用度的关键方法之一。我们希望本综述能为今后冬凌草甲素的研究提供一些启示。